大洋生物: 关于收到浙江监管局对公司股东杨兴礼及其一致行动人采取责令改正措施的公告

Group 1 - The company received a decision from the Zhejiang Regulatory Bureau regarding shareholder Yang Xingli and his concerted actions, which mandated corrective measures due to a violation of disclosure regulations [1][2] - Yang Xingli and his associates failed to timely notify the company and announce their shareholding increase of 1% after surpassing the 5% threshold of total issued shares, violating specific articles of the "Measures for the Administration of the Acquisition of Listed Companies" [1][2] - The regulatory decision requires the shareholders to submit a written rectification report within 10 working days and emphasizes the need for improved awareness of stock trading regulations to prevent future violations [2] Group 2 - The company promptly communicated the regulatory decision to relevant shareholders and reminded them to adhere strictly to legal and regulatory requirements for information disclosure [2] - The matter does not involve the company or other shareholders and will not affect the company's normal business operations [2]